These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31972315)

  • 1. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population.
    Kjaergaard AD; Helby J; Johansen JS; Nordestgaard BG; Bojesen SE
    Clin Microbiol Infect; 2020 Oct; 26(10):1411.e1-1411.e9. PubMed ID: 31972315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population.
    Kjaergaard AD; Nordestgaard BG; Johansen JS; Bojesen SE
    Int J Cancer; 2015 Dec; 137(11):2696-704. PubMed ID: 26095694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measured and genetically predicted plasma YKL-40 levels and melanoma mortality.
    Ismail H; Helby J; Hölmich LR; Chakera AH; Bastholt L; Klyver H; Sjøgren P; Schmidt H; Schöllhammer L; Johansen JS; Nordestgaard BG; Bojesen SE
    Eur J Cancer; 2019 Nov; 121():74-84. PubMed ID: 31563729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies.
    Kjaergaard AD; Bojesen SE; Nordestgaard BG; Johansen JS
    Clin Chem; 2014 Nov; 60(11):1429-40. PubMed ID: 25225167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
    Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P
    Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma YKL-40 levels and ischemic stroke in the general population.
    Kjaergaard AD; Bojesen SE; Johansen JS; Nordestgaard BG
    Ann Neurol; 2010 Nov; 68(5):672-80. PubMed ID: 21031582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YKL-40 levels and atrial fibrillation in the general population.
    Marott SC; Benn M; Johansen JS; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG
    Int J Cardiol; 2013 Aug; 167(4):1354-9. PubMed ID: 22525348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
    Johansen JS; Bojesen SE; Mylin AK; Frikke-Schmidt R; Price PA; Nordestgaard BG
    J Clin Oncol; 2009 Feb; 27(4):572-8. PubMed ID: 19075264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity.
    Coriati A; Bouvet GF; Massé C; Ducruet T; Berthiaume Y
    J Cyst Fibros; 2021 Nov; 20(6):e93-e99. PubMed ID: 33277205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal assessment of circulating YKL-40 levels in preschool children with wheeze.
    James A; Stenberg Hammar K; Reinius L; Konradsen JR; Dahlén SE; Söderhäll C; Hedlin G
    Pediatr Allergy Immunol; 2017 Feb; 28(1):79-85. PubMed ID: 27732738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma YKL-40 and total and disease-specific mortality in the general population.
    Johansen JS; Bojesen SE; Tybjaerg-Hansen A; Mylin AK; Price PA; Nordestgaard BG
    Clin Chem; 2010 Oct; 56(10):1580-91. PubMed ID: 20798353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic variation in CHI3L1 is associated with bronchial asthma.
    Shao J; Yang X; Ren D; Luo Y; Lai W
    Arch Physiol Biochem; 2021 Jun; 127(3):279-284. PubMed ID: 31295039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Crit Rev Clin Lab Sci; 2016 Dec; 53(6):396-408. PubMed ID: 27187575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHI3L1 polymorphisms, cord blood YKL-40 levels and later asthma development.
    Usemann J; Frey U; Mack I; Schmidt A; Gorlanova O; Röösli M; Hartl D; Latzin P
    BMC Pulm Med; 2016 May; 16(1):81. PubMed ID: 27193312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic regulation of YKL-40 in childhood.
    Guerra S; Melén E; Sunyer J; Xu CJ; Lavi I; Benet M; Bustamante M; Carsin AE; Dobaño C; Guxens M; Tischer C; Vrijheid M; Kull I; Bergström A; Kumar A; Söderhäll C; Gehring U; Dijkstra DJ; van der Vlies P; Wickman M; Bousquet J; Postma DS; Anto JM; Koppelman GH
    J Allergy Clin Immunol; 2018 Mar; 141(3):1105-1114. PubMed ID: 28739286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
    Keles ZP; Keles GC; Avci B; Cetinkaya BO; Emingil G
    J Periodontol; 2014 Sep; 85(9):1240-6. PubMed ID: 24635545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population.
    Kjaergaard AD; Johansen JS; Nordestgaard BG; Bojesen SE
    J Med Genet; 2013 Dec; 50(12):831-7. PubMed ID: 24062521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease.
    Wu S; Hsu LA; Cheng ST; Teng MS; Yeh CH; Sun YC; Huang HL; Ko YL
    Int J Mol Sci; 2014 Dec; 15(12):22421-37. PubMed ID: 25486056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.